CIK 0001770787
- Large accelerated filer
10x Genomics, Inc.
Sign in to watch- Ticker
- TXG
- Exchange
- Nasdaq
- Industry
- Laboratory Analytical Instruments
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 455614458
- Phone
- +1 925-401-7300
- Business address
- 6230 STONERIDGE MALL ROAD, PLEASANTON, CA, 94588
- 4 Open-market sale Chief Financial Officer sold 1,679 shares at $43.34 ($72,762)
- 4 Open-market sale Chief Executive Officer sold 7,480 shares at an average $43.52 ($325,567)
- 4 Open-market sale Chief Commercial Officer sold 14,718 shares at $42.09 ($619,494)
- 4 Planned sale Chief Executive Officer sold 2,000 shares at $39.52 ($79,041)
- 4 Planned sale Chief Executive Officer sold 2,000 shares at an average $39.51 ($79,017)
- 4 Planned sale Chief Executive Officer sold 2,000 shares at an average $49.37 ($98,739)
- 4 Open-market sale Chief Executive Officer sold 3,757 shares at $45.78 ($172,000)
- 4 Open-market sale Chief Financial Officer sold 1,678 shares at $45.78 ($76,821)
- 4 Open-market sale Chief Commercial Officer sold 9,699 shares at $45.78 ($444,031)
- 4 Open-market sale Hindson Benjamin J. sold 3,449 shares at $45.78 ($157,899)
- 4 Planned sale Chief Executive Officer sold 2,000 shares at an average $50.11 ($100,212)
- 4 Planned sale Hindson Benjamin J. sold 6,970 shares at an average $62.21 ($433,612)
- 4 Planned sale Chief Executive Officer sold 40,000 shares at $60.03 ($2,401,088)
- 4 Planned sale Hindson Benjamin J. sold 13,940 shares at $60.03 ($836,834)
- 4 Planned sale Chief Executive Officer sold 2,000 shares at an average $58.05 ($116,090)
- 4 Grant or award Director acquired 1,865 shares (grant or award)
- 4 Grant or award Director acquired 1,865 shares (grant or award)
- 4 Grant or award Director acquired 1,865 shares (grant or award)
- 4 Grant or award Director acquired 1,865 shares (grant or award)
- 4 Grant or award Director acquired 1,865 shares (grant or award)
Page 6 of 21 · 410 filings